700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02438

Synthetic patientMETA-24 · Day 128 · 25–34 · M · baseline S01Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S01
  2. Day 29 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 29.

Primary contributors, last 14 days
  • GI instability-8
  • Inflammatory activity-8
  • Nutritional resilience+5
  • Toxicity-3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    72 min
    worsening · -5.9 vs previous 14 d
    Sleep duration
    Wearable
    7.3 h
    stable · -0.3 vs previous 14 d
    Energy level
    Daily log
    6.2/10
    worsening · -0.3 vs previous 14 d
    Steps
    Wearable
    8,103
    worsening · -486 vs previous 14 d
    GI burden
    Companion
    11.2/100
    worsening · +8.2 vs previous 14 d
    Adherence
    Companion
    77.8 %
    stable · -3.1 vs previous 14 d
    Sleep quality
    Wearable
    57.9/100
    worsening · -5.7 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    129 mg/dL
    worsening · +8.6 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 75 from the failing basin, 46 from restoration.

    Good elements to keep
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein (supports)
      perturbation · steering +6.1
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -3.4 next day
    Main detractors to watch
    • FUT2 non-secretor
      hidden · steering -10.6
    • Rapid metabolizer
      hidden · steering -8
    • Histamine load
      perturbation · steering -8
    • Low microbial diversity
      hidden · steering -7.7
    • Histamine load
      detractor · GI +4.9 next day
    • Ultra-processed food
      detractor · GI +3.7 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Histamine load
      +4.9detractor · 95%
    • Ultra-processed food
      +3.7detractor · 95%
    • Protein
      -3.4supporter · 87%
    • Simple carbohydrates
      +2.1no signal · 49%
    • Alcohol
      +2detractor · 59%
    • Dietary fat load
      +1.1no signal · 27%
    • Insoluble fibre
      +0.2no signal · 15%
    • Caffeine
      0no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity ↓30
      • DNAFUT2 non-secretor lowers mucosal fucosylation
    • Inflammatory signalling ↓20
      • MicrobiomeBacteroides fragilis expansion
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • CYP2D6 Rapid metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.9 · butyrate capacity 62/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    60 ms
    Sleep
    7.6 h
    Steps
    7,508
    Resting HR
    58 bpm
    Daily log: GI score 11, nutritional resilience 72, adherence 78.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0269826%S06ME-01improved71
    P-0221425%S08SC-12no change69
    P-0229325%S15HY-01no change68
    P-0244225%S14——68
    P-0246325%S18——68
    P-0244125%S11SC-12improved67
    P-0265826%S04——66
    P-0209525%S08——66
    P-0246225%S12DT-01improved65
    P-0247625%S05——65
    P-0242325%S10——65
    P-0254025%S06——64